Cameron Durrant Insider Profile
11 Followers
Cameron Durrant, former Director at Immune Pharmaceuticals, holds 70.00K shares in Humanigen (Ticker: HGENQ), holds 4.00K shares in Immune Pharmaceuticals (Ticker: IMNPQ), holds 0.00 shares in Hi-Tech Pharmacal Co., Inc. (Ticker: HITK). Most recently, Cameron Durrant Bought ― shares of Humanigen on Mar 04, 2022 for an estimated value of $93.60K.
Cameron Durrant's Trading History
| HGENQHumanigen | Mar 04, 2022 | ― | Informative Buy | 93.60K | $770.00 | |
| IMNPQImmune Pharmaceuticals | Dec 03, 2014 | ― | Informative Buy | 10.00K | $40.00 | |
| HITKHi-Tech Pharmacal Co., Inc. | ― | ― | ― | ― |
You May Also Like
Cameron Durrant insider profile FAQ
What is the percentage of profitable transactions made by Cameron Durrant?
The percentage of profitable transactions made by Cameron Durrant is 33%.
What is the average return per transaction made by Cameron Durrant?
The average return per transaction made by Cameron Durrant is -24.10%.
What stocks does Cameron Durrant hold?
Cameron Durrant holds: IMNPQ, HGENQ, HITK stocks.
What was Cameron Durrant’s latest transaction?
Cameron Durrant’s latest transaction was an Informative Buy of $93.60K.
What was Cameron Durrant's most profitable transaction?
Cameron Durrant’s most profitable transaction was an Informative Sell of HGENQ stock on June 16, 2021. The return on the trade was 87.30%.
What is Cameron Durrant's role in Immune Pharmaceuticals?
Cameron Durrant's role in Immune Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
